These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 23555247)

  • 1. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses.
    Wang B; Xi X; Lei X; Zhang X; Cui S; Wang J; Jin Q; Zhao Z
    PLoS Pathog; 2013 Mar; 9(3):e1003231. PubMed ID: 23555247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterovirus 2Apro targets MDA5 and MAVS in infected cells.
    Feng Q; Langereis MA; Lork M; Nguyen M; Hato SV; Lanke K; Emdad L; Bhoopathi P; Fisher PB; Lloyd RE; van Kuppeveld FJ
    J Virol; 2014 Mar; 88(6):3369-78. PubMed ID: 24390337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage.
    Qian S; Fan W; Liu T; Wu M; Zhang H; Cui X; Zhou Y; Hu J; Wei S; Chen H; Li X; Qian P
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential Role of Enterovirus 2A Protease in Counteracting Stress Granule Formation and the Induction of Type I Interferon.
    Visser LJ; Langereis MA; Rabouw HH; Wahedi M; Muntjewerff EM; de Groot RJ; van Kuppeveld FJM
    J Virol; 2019 May; 93(10):. PubMed ID: 30867299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling.
    Mukherjee A; Morosky SA; Delorme-Axford E; Dybdahl-Sissoko N; Oberste MS; Wang T; Coyne CB
    PLoS Pathog; 2011 Mar; 7(3):e1001311. PubMed ID: 21436888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of enterovirus 71 replication and viral 3C protease by quercetin.
    Yao C; Xi C; Hu K; Gao W; Cai X; Qin J; Lv S; Du C; Wei Y
    Virol J; 2018 Jul; 15(1):116. PubMed ID: 30064445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of MDA5-Mediated Innate Immune Responses by the 3C Proteins of Coxsackievirus A16, Coxsackievirus A6, and Enterovirus D68.
    Rui Y; Su J; Wang H; Chang J; Wang S; Zheng W; Cai Y; Wei W; Gordy JT; Markham R; Kong W; Zhang W; Yu XF
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28424289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newcastle Disease Virus V Protein Degrades Mitochondrial Antiviral Signaling Protein To Inhibit Host Type I Interferon Production via E3 Ubiquitin Ligase RNF5.
    Sun Y; Zheng H; Yu S; Ding Y; Wu W; Mao X; Liao Y; Meng C; Ur Rehman Z; Tan L; Song C; Qiu X; Wu F; Ding C
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31270229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
    Vazquez C; Tan CY; Horner SM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enterovirus 71 3C inhibits cytokine expression through cleavage of the TAK1/TAB1/TAB2/TAB3 complex.
    Lei X; Han N; Xiao X; Jin Q; He B; Wang J
    J Virol; 2014 Sep; 88(17):9830-41. PubMed ID: 24942571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.
    He Z; Zhu X; Wen W; Yuan J; Hu Y; Chen J; An S; Dong X; Lin C; Yu J; Wu J; Yang Y; Cai J; Li J; Li M
    J Virol; 2016 Aug; 90(16):7219-7230. PubMed ID: 27252539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3.
    Lei X; Sun Z; Liu X; Jin Q; He B; Wang J
    J Virol; 2011 Sep; 85(17):8811-8. PubMed ID: 21697485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response.
    Xu C; He X; Zheng Z; Zhang Z; Wei C; Guan K; Hou L; Zhang B; Zhu L; Cao Y; Zhang Y; Cao Y; Ma S; Wang P; Zhang P; Xu Q; Ling Y; Yang X; Zhong H
    J Virol; 2014 Oct; 88(19):11356-68. PubMed ID: 25056901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyruvate Carboxylase Activates the RIG-I-like Receptor-Mediated Antiviral Immune Response by Targeting the MAVS signalosome.
    Cao Z; Zhou Y; Zhu S; Feng J; Chen X; Liu S; Peng N; Yang X; Xu G; Zhu Y
    Sci Rep; 2016 Feb; 6():22002. PubMed ID: 26906558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic analysis of cells in response to EV71 infection and 2A
    Yao C; Hu K; Xi C; Li N; Wei Y
    Genes Genomics; 2019 Mar; 41(3):343-357. PubMed ID: 30499052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns.
    Hsiao HB; Chou AH; Lin SI; Chen IH; Lien SP; Liu CC; Chong P; Liu SJ
    J Virol; 2014 Oct; 88(20):11658-70. PubMed ID: 25078697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral Potential of a Novel Compound CW-33 against Enterovirus A71 via Inhibition of Viral 2A Protease.
    Wang CY; Huang AC; Hour MJ; Huang SH; Kung SH; Chen CH; Chen IC; Chang YS; Lien JC; Lin CW
    Viruses; 2015 Jun; 7(6):3155-71. PubMed ID: 26090728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage of 14-3-3ε by the enteroviral 3C protease dampens RIG-I-mediated antiviral signaling.
    Andrews DDT; Vlok M; Akbari Bani D; Hay BN; Mohamud Y; Foster LJ; Luo H; Overall CM; Jan E
    J Virol; 2023 Aug; 97(8):e0060423. PubMed ID: 37555661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1.
    Lu J; Yi L; Zhao J; Yu J; Chen Y; Lin MC; Kung HF; He ML
    J Virol; 2012 Apr; 86(7):3767-76. PubMed ID: 22258259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity-Based Protein Profiling Identifies ATG4B as a Key Host Factor for Enterovirus 71 Proliferation.
    Sun Y; Zheng Q; Wang Y; Pang Z; Liu J; Yin Z; Lou Z
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31554687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.